Dr. Choudry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 University Dr
H088
Hershey, PA 17033Phone+1 717-531-1692
Summary
- I am currently an Associate Professor of Surgery in the Division of Surgical Oncology, Department of Surgery, at the University of Pittsburgh Medical Center. I completed my surgical residency training at Penn State University Medical Center and Surgical Oncology fellowship at the University of Pittsburgh Medical Center. I have a broad clinical practice that includes primary gastrointestinal malignancies, sarcomas, melanomas, neuroendocrine tumors, as well as some hepato-pancreato-biliary surgery. I have significant experience with laparoscopic and robotic surgery. I have a particular interest in the management of patients with peritoneal surface malignancies and peritoneal metastases, including cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion. I lead my own NIH-funded basic science/ translational research laboratory. The overall goal of my research has been to elucidate the role of mucin 2 (MUC2) protein in the tumor biology of mucinous colorectal and appendix cancer, determine whether modulation of mechanisms associated with MUC2 protein production impacts tumor growth and chemosensitivity, and identify novel mucin-inhibitory and mucolytic agents that may be translated to clinical trials. At a national level, I serve as an editorial board member in the Gastrointestinal Oncology Section of the Annals of Surgical Oncology, the official journal of the Society of Surgical Oncology. I was nominated to the Society of Surgical Oncology Task Force Committee tasked with creating clinical pathways and billing/coding standards for peritoneal surface malignancies in 2018. I was also nominated to the Society of Surgical Oncology peritoneal surface malignancy working group in 2018 tasked with developing and expanding educational initiatives, developing cross-collaborations, and improving clinical care for such diseases.
Education & Training
- Penn State Milton S Hershey Medical CenterResidency, Surgery, 2001 - 2008
- Aga Khan Medical CollegeClass of 1999
Certifications & Licensure
- PA State Medical License 2007 - 2026
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow American College of Surgeons
Publications & Presentations
PubMed
- A machine learning approach for predicting textbook outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Amir Ashraf Ganjouei, Fernanda Romero-Hernandez, Jaeyun Jane Wang, Ahmed Hamed, Ahmed Alaa
World Journal of Surgery. 2024-06-01 - CD8 + T-cell Density Is an Independent Predictor of Survival and Response to Adjuvant Chemotherapy in Stage III Colon Cancer.Paulo Garcia, Douglas Hartman, Haroon Choudry, Reetesh K Pai
Applied Immunohistochemistry & Molecular Morphology. 2023-02-01 - 6 citationsDNA Mismatch Repair-deficient Rectal Cancer Is Frequently Associated With Lynch Syndrome and With Poor Response to Neoadjuvant Therapy.Lama F Farchoukh, James Celebrezze, David Medich, Kellie Cunningham, Jennifer Holder-Murray
The American Journal of Surgical Pathology. 2022-09-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: